Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 2:07 AM ET

Life Sciences Tools and Services

Company Overview of Buck Institute For Age Research

Company Overview

Buck Institute For Age Research operates a non-profit scientific research institute. Its facility focuses on understanding the connection between aging and chronic diseases. The company also develops regenerative medicine and aging programs. Buck Institute For Age Research was founded in 1985 and is based in Novato, California.

8001 Redwood Boulevard

Novato, CA 94945

United States

Founded in 1985





Key Executives for Buck Institute For Age Research

Chief Executive Officer and President
Age: 48
Chief Financial Officer and Vice President of Finance
Chief Operating Officer and General Counsel
Senior Vice President for Institute Relations
Director of Communications
Compensation as of Fiscal Year 2015.

Buck Institute For Age Research Key Developments

Mount Tam Biotechnologies Signs on License Agreement with Buck Institute for Age Research

Mount Tam Biotechnologies has entered into a worldwide licensing and collaboration agreement with the Buck Institute for Age Research. The agreement includes the Institute's advanced research and development assets in the area of autoimmune disorders. The license contains TAM-01, a pre-IND stage compound, which represents a therapeutic for the treatment of systemic lupus erythematosus (SLE) the common form of lupus. In addition, the agreement also includes other, earlier stage compounds and an extensive library of assets positioned in the autoimmune disease space.

Ultragenyx Pharmaceutical Inc. Executes Amendment No. 2 to License and Services Agreement with the Buck Institute for Research on Aging

Ultragenyx Pharmaceutical Inc. executed Amendment No. 2 to License and Services Agreement, which amends that certain License and Services Agreement, dated as of September 24, 2010, between the company and The Buck Institute for Research on Aging (Buck), which was previously amended by that certain Amendment No. 1 to License and Services Agreement, dated as of September 4, 2012 (as so amended, the Agreement). The amendment is deemed effective as of September 15, 2014 and amends the agreement by providing the company with certain additional laboratory and office space, increasing the annual and monthly rent to $305,000.00 and $25,416.67, respectively, and giving the company a right of first refusal to license additional space, at a fee of $73,872 per year, during the term of the amendment. Additionally, the amendment extends the term of the agreement to continue through September 15, 2019, which term may be extended by an additional twelve months for up to three consecutive years. The amendment also grants the company an exclusive license to use certain equipment.

Chester Aldridge Joins Buck Advisory Council

Chester Aldridge, Chairman and CEO of US Equity Holdings, has joined the Buck Institute's Buck Advisory Council (BAC). The long-time Marin resident will take an active role in advising the Institute on the commercialization of some of its most promising research assets. At US Equity Holdings, Aldridge has established, financed and managed multiple ventures in the fields of entertainment, biotechnology, and renewable energy. Over the last several months, Aldridge and the US Equity Holdings team have accelerated their licensing deals and are quickly moving toward the establishment of a strategy that leads to the commercialization of some key assets and discoveries from the Buck Institute, under a new venture known as Project Golden State.

Similar Private Companies By Industry

Company Name Region
Tioga Research, Inc. United States
Eksigent Technologies, Inc. United States
Vortex Biosciences, Inc. United States
Lifecycle Sciences Group United States
McArdle & Associates, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Buck Institute For Age Research, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at